District of Columbia Code
Subchapter II - Access to Treatment for Anaphylaxis
§ 7–2381.05. Storing and maintaining epinephrine

(a) An authorized entity may acquire and maintain epinephrine auto-injectors obtained in accordance with § 7-2381.02. Once acquired, the epinephrine auto-injectors shall be maintained:
(1) In a location readily accessible in an emergency situation;
(2) In accordance with the manufacturer's instructions for storage; and
(3) In accordance with any additional requirements that may be established by the Department.
(b) An authorized entity shall designate employees or agents who have completed the training described in § 7-2381.04 to be responsible for the storage and maintenance of epinephrine auto-injectors acquired by the authorized entity.
(Feb. 22, 2019, D.C. Law 22-207, § 6, 65 DCR 12365.)
Applicability of D.C. Law 22-207: § 7155 of D.C. Law 23-16 repealed § 10 of D.C. Law 22-207. Therefore the creation of this section by D.C. Law 22-207 has been implemented.
Applicability of D.C. Law 22-207: § 10 of D.C. Law 22-207 provided that the creation of this section by § 6 of D.C. Law 22-207 is subject to the inclusion of the law’s fiscal effect in an approved budget and financial plan. Therefore that amendment has not been implemented.
For temporary (90 days) repeal of applicability provision of D.C. Law 22-207, see § 7155 of Fiscal Year 2020 Budget Support Congressional Review Emergency Act of 2019 (D.C. Act 23-112, Sept. 4, 2019, 66 DCR 11964).
For temporary (90 days) repeal of applicability provision of D.C. Law 22-207, see § 7155 of Fiscal Year 2020 Budget Support Emergency Act of 2019 (D.C. Act 23-91, July 22, 2019, 66 DCR 8497).